Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Li, X.
Li, J.
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
bevacizumab; Cisplatin; malignant pleural effusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-041
引用
收藏
页码：S2084 / S2084
页数：1
相关论文
共 50 条
  • [41] Pemetrexed (PEM) Plus Platinum-based Regimen as First Line Treatment in Unselected Patients Affected With Non-squamous Non-small-cell Lung Cancer (NSCLC): a Retrospective Multicenter Analysis
    Moscetti, L.
    Fabbri, M. A.
    Narducci, F.
    Mansueto, G.
    Longo, F.
    Martelli, O.
    Angelini, F.
    Pavese, I.
    Ruggeri, E. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S617 - S617
  • [42] Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
    G. P. Stathopoulos
    D. Antoniou
    J. Dimitroulis
    J. Stathopoulos
    K. Marosis
    P. Michalopoulou
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 945 - 950
  • [43] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
  • [44] Safety of Bevacizumab (Bv) in Superannuated Patients with Non-squamous Non-small Cell Lung Cancer
    Charpidou, Andriani
    Vassos, Dimitrios
    Tsimpoukis, Sotirios
    Demertzis, Panagiotis
    Gkiozos, Ioannis
    Syrigos, Kostas
    CHEST, 2014, 145 (03)
  • [45] The cost-effectiveness of bevacizumab plus cisplatin and gemcitabine (BCG) compared with pemetrexed plus cisplatin (PC) induction treatment of advanced non-squamous non-small cell lung cancer (NSCLC) in Germany.
    Bischoff, H.
    Hermes, A.
    Gatzemeier, U.
    Heigener, D. F.
    Cesaro-Tadic, S.
    Walzer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    THORACIC CANCER, 2014, 5 (04) : 289 - 296
  • [47] Bevacizumab, When Added To Pemetrexed/platinum, Prolongs Survival In Previously Untreated Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer In Japan
    Mouri, A.
    Arimoto, Y.
    Takeoka, S.
    Honma, C.
    Fukusumi, M.
    Hamamoto, Y.
    Kamimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] COMPARISON OF EFFICACY OF PEMETREXED PLUS PLATINUM AND NON-PEMETREXED PLUS PLATINUM AS 1ST LINE CHEMOTHERAPY IN EGFR WILD TYPE NON-SQUAMOUS NSCLC
    Kang, E. J.
    Lee, S. Y.
    Kim, J. S.
    ANNALS OF ONCOLOGY, 2015, 26
  • [49] Re-audit of use of pemetrexed/cisplatin for non-squamous non-small-cell lung cancer in Northern Ireland
    McDermott, R.
    Campbell, L.
    Hurwitz, J.
    Scullin, P.
    LUNG CANCER, 2012, 75 : S8 - S8
  • [50] Maintenance pemetrexed immediately following induction treatment with pemetrexed plus cisplatin for advanced non-small-cell non-squamous carcinoma of the lung - a single institution experience
    Kim, D.
    Gilani, S. N.
    Giridharan, S.
    Sule-Suso, J.
    Jegannathen, A.
    LUNG CANCER, 2015, 87 : S24 - S24
12345